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Abstract: The 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine-2-thione scaffold have found many applications in recent 
years. This review is aimed at highlighting the most important aspects about these compounds: synthesis, spectroscopic 
characterization and antiprotozoan activities. How the chemical nature of N-substituents influences the overall activity / 
cytotoxicity profile will also be discussed. 
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1. INTRODUCTION 
  Trypanosomatids are parasitic protozoa responsible for 
several tropical diseases of which African sleeping sickness 
(Trypanosoma brucei gambiense and T. b. rhodesiense), 
Chagas disease (T. cruzi), and the different forms of 
leishmaniasis (Leishmania donoVani and L. infantum) are 
considered the most lethal [1]. At present, the chemothera-
pies associated with all forms of trypanosomiasis have many 
deficiencies, among them, poor efficacy, toxicity to humans, 
high cost, and the emergence of drug-resistant parasitic 
strains [2]. Unfortunately, because of the low profit margins 
associated with developing improved therapies for tropical 
diseases, there is no motivation for the pharmaceutical indus-
try to develop better tropical disease drugs. Accordingly, 
many agencies, including the Special Program for Research 
and Training in Tropical Diseases at the World Health Orga-
nization (WHO/TDR), numerous academic research groups, 
various international/national bodies, and philanthropic 
foundations, have been sponsoring the discovery of new 
drug candidates for a number of tropical diseases [3]. 
 Recently,  the  tetrahydro-2H-1,3,5-thiadiazine-2-thione 
(THTT) derivatives have received special attention due to 
the pharmacological properties that they display like anti-
parasitic agents. Although the 3,5-disubstituted tetrahydro-
2H-1,3,5-thiadiazine-2-thione (mono-THTT) scaffold (Fig. 1) 
was synthesized for the first time in 1848 [4], its accurate 
structure was established in 1944 [5]. The first publications 
of these compounds pointed out the significance of the na-
ture of the substituent at N-3 on antimicrobial activity [6], 
and toxicity of the substituent on N-5 has been shown [7].  
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Optimum activities had been obtained in compounds bearing 
lipophilic groups at the N-3 and hydrophilic ones at 5
th posi-
tion [8]. 
  The principal studies on the THTT derivatives [9-26] 
take into account the molecular structure of these molecules 
to obtain the best activity/cytotoxicity relation. In this con-
text, we found in the bibliography the reports on many com-
pounds with one THTT ring as the central core with a great 
variety of substituents in N-3 and N-5 position (mono-
THTT) [9-18]. In the last years, to enhance the antiprotozoal 
effect two THTT rings were incorporated into the same mo-
lecular structure, connected to each other via their N-3 atom 
by a linear or branch aliphatic backbone and bearing alkyl or 
carboxyalkyl residues at N-5 (bis-THTT)[19-26] (Fig. 1). 
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Fig. (1). 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine-2-thione 
scaffold (mono-THTT) and alkyl-linked bis-(2-thioxo-[1,3,5] 
thiadiazinan-3-yl) carboxylic acids (bis-THTT). 
  Therefore this article will review the bibliography in or-
der to show the development of new antiprotozoal agents 
using the THTT ring in their structure in the last ten years. 
2. CHEMISTRY CONSIDERATIONS  
2.1. 3,5 disubstituted-tetrahydro-2H-1,3,5-thiadiazine-2-
thione (Mono-THTT) 
  The most used procedure to obtain the THTT derivatives 
is the reaction of the appropriate amine 1 with carbon disul-
fide 2 and potassium hydroxide 3, to give the dithiocarba-52    The Open Medicinal Chemistry Journal, 2011, Vol. 5  Bermello et al. 
mate potassium salt 4 (which was not isolated), followed by 
cyclocondensation with formaldehyde 5 and the selected 
amino acids [9-11, 13-15], pseudo peptides [9-11, 13-18], 
and amines or amino ester (6) [12] able to provide the nitro-
gen at 5th position of the thiadiazine ring in fair to moderate 
or good yields. In the first step of these synthetic procedures, 
water is employed as a protic polar solvent in order to stabi-
lize the dithiocarbamate intermediate 4, in the second step 
pH 7-8 phosphate buffer was used (Scheme 1) [9-18]. 
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Scheme 1. General procedure for obtaining mono THTT.  
  This methodology allowed the synthesis of 78 new 
mono-THTT derivatives to bunch up in at least seven series 
(Fig. 2). The series synthesized differ as to the nature (lipo-
philic or hydrophilic) of substituent at 3rd position. Some 
series bear an aromatic (furfuryl [9,11], benzyl [11] and D or 
L deacylated chloramphenicol [12]) and alkyl or cycloalkyl 
(ethyl, butyl, octyl, dodecyl, cyclopropyl and cyclohexyl) [9-
11, 13-18] moiety, all of them lipophilic group; for other 
series the starting amines were hydrophilic (carboxyalkyl) 
group [9].  
  Another synthetic method used to obtain these com-
pounds was the solid phase synthesis of 3-(5-carboxypentyl)-
5-substituted tetrahydro-2H-1,3,5-thiadiazin-2-thione deriva-
tives (Serie I). 6-Amino-n-hexanoic acid was attached via its 
C-terminal to hydroxymethyl polystyrene using a ‘SASRIN’ 
linker. The bound amino acid was transformed into the cor-
responding dithiocarbamate 8 followed by cyclization in the 
presence of formaldehyde and the corresponding free amino 
acids to afford 3-(5´-carboxypentyl)-5-substituted tetrahy-
dro-2H-1,3,5-thiadiazin-2-thiones (9). The final products I 
were cleaved from the resin and obtained in moderate yields 
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Fig. (2). Representative mono-THTT synthesized.  
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due to low solubility of the corresponding free amino acids 
in 1,4 dioxan (Scheme 2). 
  Although its use is limited by two factors: the possibility 
for the starting amines to be properly functionalized for the 
efficient coupling to the resin and the low solubility of the 
amino acids in the solvent employed. The development of 
this methodology would allow the generation of combinato-
rial library for THTT compounds. 
2.2. Alkyl-linked bis-(2-thioxo-[1,3,5] thiadiazinan-3-yl) 
carboxylic acids (bis-THTT) 
  The synthetic methods for obtaining bis-THTT have been 
much less reported in the bibliography than the synthetic 
route for mono-THTT [19-22]. The general procedure is very 
similar to the one used for mono-THTT. The bis-THTTs 
were always obtained using diamines 10 and the amounts of 
all reagents were duplicated. In the first step the diamine 
reacts with carbon disulfide 2 in the presence of potassium 
hydroxide 3 to obtain the expected bisdithiocarbamate salt 
11. The addition of formaldehyde 5 and the corresponding 
amine or aminoacid (6) to 11 resulted in the cyclocondensa-
tion in a slightly alkaline medium (phosphate buffer, pH 7-8) 
to generate, after treatment with HCl 15%, the desired bis-
THTT (Scheme 3) [19-21]. 
  This procedure allowed the synthesis of 43 new bis-
THTT derivatives to bunch up in at least four series (Fig. 3). 
All compounds were obtained in moderate to good yields 
except those of series IX, probably due to the use of a bulky 
diamine (2,2-dimethyl-1,3-propanediamine) and the resulting 
steric hindrance at the cyclization stage. 
  Recently, our group explored the feasibility of synthesis 
of new bis-THTT using more complex polyamines as link-
age other than the initially reported diamines [22]. The N4-
benzyl polyamine 14 was previously synthesized according 
to a methodology reported by O'Sullivan et al. [23] via a 
protection-deprotection strategy using ethyl trifluoroacetate 
as the selective protective group for primary amines in the 
presence of secondary amines. The synthetic route leading to 
derivatives of serie XII from the benzylated spermidine was 
similar to the one described above (Scheme 4). 
  The spermidyl linked bis-THTT series (XII) were ob-
tained as solids in moderate yields. 
  The experimental procedure used to obtain the THTT 
derivatives (mono and bis-THTT) is simple, allowing a 
wealth of molecular diversity depending on the nature of 
groups attached to both nitrogens (N-3 and N-5) of the het-
erocycle.  
2.3. Proposed Reaction Mechanism for the Generation of 
the Thiadiazine Ring 
  According to the authors, the formation of the thiadiaz-
inane ring is performed via a one pot domino reaction be-
tween the pre-formed DTC, formaldehyde and the amino 
acid component. Despite being considered a multi-
component reaction, the reactants are added in a stepwise 
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Scheme 3. General procedure for obtaining bis-THTT. 
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fashion. Undoubtedly, one of the least explored aspects re-
garding the synthesis of THTT has been the study of the re-
action pathway from the corresponding DTC. In one ap-
proach (Scheme 5a) the preformed DTC 4 is allowed to react 
simultaneously with formaldehyde and the corresponding 
amine to produce [substituted(aminomethyl)methane-
thionyl]methylidenazanium 12 [20]. This species possesses 
two different reactive centers in the same molecular back-
bone, a protonated imine and a thiosulfanylmethylamino 
group. The intramolecular addition of the secondary amino 
group to the carbon atom of the methylidene moiety leads to 
the THTT ring. The formation of the THTT ring via a {[hy-
droxymethyl (substituted) carbamothioyl] sulfanyl}methanol 
intermediate 13 [13] was proposed (Scheme 5b). This proc-
ess involves in situ generation of 13 from the corresponding 
DTC 4 and formaldehyde (5) followed by condensation with 
a primary amine. The isolation and characterization of an 
analogue of 13, via a crystallization process induced by the 
presence of KOH, was reported [13]. 
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Scheme 5. Proposed reaction mechanism for the generation of the 
THTT ring. 
  Recently, we have reported a preliminary DFT study 
aimed at predicting the probable cyclization mechanism of 
the thiadiazinane-2-thione from an intermediate of type 13 
[24]. Based on experimental facts and DFT studies, a prob-
able cyclization route to the THTT ring from the correspond-
ing {[hydroxymethyl(substituted) carbamothioyl] sul-
fanyl}methanol intermediate 13 in aqueous medium is pro-
posed. Notably, water not only contributes to the reaction as 
a mere solvent, but also plays an active role in the reaction 
mechanism. As far as we know, this is the first computa-
tional study on the formation of the thiadiazinane-2-thione 
ring. 
3. STRUCTURAL CHARACTERIZATION OF MONO 
AND BIS-THTT DERIVATIVES 
  Structures of all the compounds were established on         
the basis of spectroscopic data and microanalysis. IR spec-
troscopy of the compounds showed absorption bands ranging 
from 3060 to 3450 cm
1 for (OH and NH), 1690 to 1720cm
1 
for (C=O) and from 1445 to 1508 cm
1 for (C=S). Although, 
numerous studies have been published on the synthesis and 
characterization of these compounds [9-14], it was only in 
2001 we published the first exhaustive structural characteri-
zation of mono-THTT derivatives [15-17]. These studies 
were considered an important structural data base to facili-
tate the characterization of novel compounds with the THTT 
ring in its structure. 
  The Nuclear Magnetic Resonance study deals with the 
complete 
1H and 
13C NMR assignments of a series of differ-
ently substituted THTT endowed with different organic ad-
dends on both heterocyclic nitrogen atoms (Fig. 4). The 
1H 
NMR spectra at 300 MHz of THTT derivatives show, in 
general, two singlets corresponding to ring protons H-4 and 
H-6 around  4.50 and 4.40 respectively, besides other usual 
signals of the substituents. In order to assign unequivocally 
all NMR signals, 1D and 2D techniques such as DEPT (135), 
HMQC and HMBC were used [15]. 
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Fig. (4). Compounds studies by NMR 1D and 2D techniques.  
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  A structural study of 5-carboxy-ethyl-3-(2´-furfurylmet-
hyl) tetrahydro-2H-1,3,5-thiadiazine-2-thione was made by 
means of X-ray crystallographic analysis determining the 
most stable conformation in the solid state. The theoretical 
calculations allowed to gain a better picture of the conforma-
tional profile of the given compound by means of the 
semiempirical AM1 method, as well as by ab-initio calcula-
tions at Hartree-Fock level using 3.21G* and 6-31G* basis 
sets. 
1H Noe experiments had also been carried out in order 
to obtain information about the conformational profile of this 
compound in solution [16].  
  The electrospray ionisation (ESI) in negative mode of the 
pharmacologically significant mono-THTT derivatives, and 
their subsequent fragmentations using an ion-trap mass spec-
trometer were investigated. Experiments on sequential prod-
uct ion fragmentations (MS
n) were performed in order to 
elucidate the degradation pathways for these compounds. 
The data reported show that the fragmentation of the even-
electron [M-H]
- ions could proceed through an internal nu-
cleophilic substitution displacement. Decarboxylation and 
extrusion of carbon disulfide are other fragmentations ob-
served [17]. 
  On the other hand, the spectroscopic information gath-
ered from previously synthesized mono-THTT derivatives 
[15-17] allowed to confirm the structure of the bis-THTT 
compounds. The structures of all the bis-THTT derivatives 
reported in the bibliography were established on the basis of 
spectroscopic data [19-22, 24, 25]. In general the 
1H and 
13C 
NMR signals of each THTT-ring were undistinguishable and 
all series, show a similar trend in the chemical shift of the 
common part of the molecular backbone. The 
1H and 
13C 
NMR spectroscopic data of alkyl, and polyamine-linked 
bis(2-thioxo-[1,3,5]thiadiazinan-3-yl) carboxylic acids, pre-
pared from alkyl diamines and N4-(benzyl) spermidine, were 
fully assigned by the combination of one- and two-
dimensional experiments (DEPT, HMBC, HMQC, COSY) 
[25]. In some cases, the 
13C NMR experiments could not be 
performed because the bis-THTT derivatives were poorly 
soluble in DMSO at the concentration required for NMR 
spectroscopy [19, 20]. 
4. BIOLOGICAL ACTIVITY OF THTT DERIVA-
TIVES 
  The promising results of antiprotozoal activity achieved 
by reported THTT derivatives could be attributed to the in-
teraction of cysteine proteinases, present in most groups of 
parasitic protozoa [26], with isothiocyanates [27] generated 
by hydrolysis of the THTT ring in a protic medium [28]. 
Notwithstanding it should not be excluded the possible inter-
action of the released aminoacids or dipeptides, attached to 
position 5 of the THTT ring, with other molecular targets, 
enhancing the antiparasitic activity observed of these deriva-
tives. 
  On the other hand, the high lipid solubility and ease of 
enzymatic hydrolysis [29] generally associated with this het-
erocycle, has motivated its use as a biolabile prodrug in the 
design of drug-delivery systems (DDS). The aforementioned 
properties and the possibility to attach several structurally 
distinct substituents to the heterocycle ring to modify either 
the biological or physico-chemical properties of these com-
pounds, have prompted us to use the THTT ring as a tem-
plate in many research programs aimed at the development 
of new antiparasitic compounds [9, 11-14, 18-22]. 
4.1. Biological Activity of Mono-THTT Derivatives 
  In 1999, we reported for the first time the antiprotozoan 
properties of 34 mono-THTT derivatives (Fig. 6) corre-
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Fig. (5). General structure of mono-THTT derivatives (Series I, II and III) assays like antiprotozoan drugs against Trichomonas vaginalis 
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sponding to the series I,  II and III against Trichomonas 
vaginalis and Trypanosoma cruzi [9]. One year later, we 
published the study on the decomposition products of their 
mono-THTT and their anticancer properties (Fig. 5) [10].  
  All mono-THTT derivatives studied showed significant 
in vitro antiprotozoan activity (both anti-trichomonas and 
anti-trypanosoma) at the highest dose tested (100 μg/mL), 
except for compound L-IIIe. (Fig. 6). The results obtained at 
10 and 1μg/mL (Fig. 7) showed that the nature of substitu-
ents not afforded important differences in the trichomocidal 
activity (%R) of the three series studied, since most of the 
compounds lose their trichomonacidal activity at 10 μg/mL. 
This fact seems to indicate that the lipophilic character of R1 
does not influence the in vitro trichomonacidal activity sig-
nificantly. Only two compounds of series III (D-IIIj and 
IIIm) maintain their efficacy at 10 μg/mL and again IIIm 
was the most active compound at 1 μg/mL (%R=59), with a 
trichomonacydal effect similar to that of Metronidazole at 
0.1 μg/mL (%R=52). None of the compounds studied were 
more active than Metronidazole (Fig. 6). The most active 
compounds, L-IIId, D-IIIj and IIIm, that were assayed in 
vivo, showed a reduction in the pathogenecity index, and this 
was mainly true for compound IIIm [9]. 
  Compounds of series II and III showed trypanosomicidal 
activity, both at 100 and 10 μg/mL, whilst compound of se-
ries I only showed cytostatic activity at 10 μg/mL. This fact 
indicated that the lipophilic substituents at the N-3 were bet-
ter than hydrophilic ones for obtaining active compounds 
against  T. cruzi. Compounds IIc,  L-IId,  DL-IId,  DL-IIf, 
IIIm and L-IIIn maintained trypanosomicidal activity at 1 
μg/mL showing a higher activity than Nifurtimox. We have 
found more compounds with trypanosomicidal than tricho-
monacidal activity (Fig. 6) [9]. 
  Taking into account the highest citotoxic activities 
showed by some compounds of the series I, II and III in a 
previous work [9], we studied the anticancer properties of 
mono-THTT derivatives (Fig. 5). This study has been carried 
out by using cytotoxicity assays against HeLa, HT-29 and 
Hep G2 cells. The decomposition products of thiadiazin-
thione IIIm have been studied and their anticancer properties 
evaluated (Fig. 7) [10]. 
  The results of this study could lead to the conclusion that 
most of the mono-THTT derivatives showed noticeable cyto-
toxic properties against HeLa and HT-29 but did not do so 
against Hep G2 cells. The compounds of series I and II 
were, in general, less cytotoxic than those of serie III, none 
 
 
Fig. (6). Percentages of reduction (positive) and/or growth (negative) at concentrations of 10 and 1μg/mL assayed in vitro against T. vagi-
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of them showed a IC50 lower than 10 μmol against any cell 
line. Compound IIIo, detected in the decomposition of com-
pound IIIm and presumingly in one of the other thiadiazi-
nones, were less cytotoxic than IIIm. The nature of R1 
modulates the cytotoxicity of these compounds. Compounds 
bearing the aromatic furfuryl moiety (Series III) yielded the 
most interesting thiadiazinones. However, the nature of R2 
influences the cytotoxic activity to a lesser grade. The (S) 
enantiomer showed more cytotoxic properties than its (R) 
isomer. Derivative (S) IIIj, bearing furfuryl and L-asparagine 
moieties, yielded the most interesting compound which is a 
candidate for a future anticancer study [10]. These results 
allowed the study through QSAR methodology of mono-
THTT derivatives using the novel hybrid index pMR [30]. 
  With the aim to increase the antiprotozoan activity spec-
tra, our group reported new biological assays to study the 
non-specific toxicity and anti-amastigote activity of 18 of 
these compounds [31]. Cytotoxicity assays of 24 mono-
THTT were performed. The 17 compounds with higher anti-
epimastigote activity and lower cytotoxicity were, therafter, 
screened against amastigote of Trypanosoma cruzi. Out of 
these 17 derivatives, (S)-IId was selected to be assayed in 
vivo, because of its remarkable trypanocidal properties. Ni-
furtimox and benzidazole were used as reference drugs. All 
of the compounds were highly toxic at 100 μg/mL for 
macrophages and a few of them maintained this cytotoxicity 
even at 10 μg/mL. Of the derivatives assayed against amas-
tigotes, Ik and (S)-IId showed an interesting activity, which 
was held even at 1 μg/mL. It is demonstrated that the high 
anti-epimastigote activity previously reported is mainly due 
to the non-specific toxicity of these compounds. In vivo as-
says assessed a reduction of parasitemia after the administra-
tion of (S)-IId to infected mice [31]. 
  In 2004 and 2005 ten mono-THTT derivatives (Fig. 8) 
were tested in vitro for antiparasitic effects against both ex-
tracellular promastigotes and intracellular amastigotes of 
Leishmania amazonensis [32,33].  The compounds were 
found to be active against the amastigote form of the para-
site, inhibiting parasite growing, from 10 to 89%, at a con-
centration of 100 μg/ml. This activity suggests that thiadiaz-
ine derivatives could be considered as potential antileishma-
nial compounds (Fig. 9) [32].  
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Fig. (8). General structure of the mono-THTT (Series III) tested in 
vitro for antiparasitic effects against both extracellular promas-
tigotes and intracellular amastigotes of Leishmania amazonensis.  
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Fig. (9). Effect of mono-THTT derivatives and Glucantine (Glu) on 
intracellular amastigote. 
  These results confirmed that the THTT represent a group 
of compounds with significant in vitro activity against L. 
amazonensis  and suggested that some of them could be 
considered for further study as new therapeuthic alternatives 
[32,33].  
  All evaluated compounds caused an irreversible inhibi-
tion of the promastigote growth either after 1h of treatment 
 
Fig. (7). Cytotoxicity (IC50 (μmol/l)) of compounds belonging to series I, II and III against HeLa, HT-29 and Hep G2 cells. 58    The Open Medicinal Chemistry Journal, 2011, Vol. 5  Bermello et al. 
with 10 μg/mL or after 24 h with 1 μg/mL (Fig. 10). How-
ever, the compounds exhibited high toxicity and produced 
inhibition of the phagocytosis in the murine host cell [33]. 
The mono–THTT tested exhibited a strong activity against L. 
amazonensis at low concentrations.  
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Fig. (10). Effects of mono-THTT derivatives III on the L. ama-
zonensis growth inhibition. A. Promastigotes were incubated in the 
presence of 10 μg/mL; after 1h of treatment (blue column); incu-
bated 5 days in fresh medium (violet columns). B 
4.2. Biological Activity of Bis-THTT Derivatives 
  It has been reported that bis-thiadiazines have antifungi-
cal, antimicrobial and antiprotozoal activity [19-22, 34]. 
Specifically with antiprotozoal activities three series of bis-
THTT had been reported [21, 22, 34]. The in vitro activity of 
compounds belonging to series VIII and IXI (Fig. 11) 
against  Leishmania donovani,  Trypanosoma brucei rhode-
siense, and Plasmodium falciparum was studied. From these 
results it may be observed (Fig. 12) that the best activity pro-
files were found against T. b. rhodesiense. It is intereresting 
that the activity against T. b. rhodesiense seems to be fa-
voured for compounds having linear aminoacidic residues as 
substituents in N-5 of the THTT ring. Despite exerting a 
notable activity against T. b. rhodesiense, derivatives from 
series VIII appeared to be more citotoxic than the analogs of 
series IX (Fig. 13) [34]. 
 The  in-vitro antiprotozoal evaluation of novel N4-
(benzyl)spermidyl-linked bis-THTT derivatives from N4-
(benzyl)spermidine (XII) was disclosed [22]. These com-
pounds showed a potent protozoocidal activity against T. 
cruzy and L. Donovani which turns to be comparable or 
greater than the currently employed chemotherapies. Despite 
this fact, the novel structures displayed a higher cytotoxicity 
than previously synthesized alkyl tethers analogs having the 
same amino acidic residues attached to position N-5 of the 
heterocyclic ring. It has been hypothesized that increased 
cytotoxicity could be related with an interference of the 
polyamine metabolism in mammals [22]. 
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Fig. (11). General structures of bis-THTT derivatives tested against 
Leishmania donovani, Trypanosoma brucei rhodesiense, and Plas-
modium falciparum. 
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Fig. (12). In vitro activity of compounds belonging to seriesVIII 
and IX against Leishmania donovani, Trypanosoma brucei rhode-
siense, and Plasmodium falciparum. 
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Fig. (13). Cytotoxicity of bis-THTT of series VIII and IX. 
 The  in-vitro antiprotozoal activity against L. donovani, T. 
cruzi, T. b. rhodesiense , and P. falciparum of some com-
pounds of series XII, was compared with these activities for 
compounds of series VIII (Fig. 14 and Fig. 15) [22]. For Thiadiazine Derivatives as Antiprotozoal New Drugs  The Open Medicinal Chemistry Journal, 2011, Vol. 5    59 
comparative purposes, structures VIII and XII were changed 
only in the nature of their connective backbone. In the bis-
THTT derivatives in both series that had the same aminoacid 
residue (R2), the displayed protozoocidal profile against the 
three parasitic lines assayed was almost the same. However, 
higher values of therapeutic indexes were found for com-
pounds VIIIa–c. Considering that both series exerted a simi-
lar protozoal activity it is possible to assume that structures 
XII are more cytotoxic than their alkyl tethers analogs [22]. 
5. CONCLUSIONS 
  The most extensive method reported to obtain THTT 
derivatives proceed via a dithiocarbamate salt intermediary. 
This experimental procedure is simple and allows a wealth 
of molecular diversity depending on the nature of groups 
attached to both nitrogens of the heterocycle.  
  All THTT synthesized showed biological activity against 
some trypanosomatids at doses of 100 μg/mL, at low doses 
some of them showed important activities. The results pre-
sented in this review made it possible to analyze how the 
chemical nature of N-3 and/or N-5-substituents in the THTT 
ring influences the overall activity/cytotoxicity profile 
against some protozoa parasites. The introduction of two 
THTT rings in the same molecule potentiated the antiproto-
zoan activity of these derivatives.  
  The excellent properties of the THTT scaffold made its 
use as the main core in many projects for the development of 
new antiparasitic agents and the synthesis of novel bis-THTT 
derivatives employing other polyamines as bridging moieties 
will be also the theme of future investigations. 
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